β-Sitosterol improves experimental colitis in mice with a target against pathogenic bacteria

Area of Science:

• Gastroenterology
• Immunology
• Pharmacology

Background:

• Inflammatory bowel disease, including colitis, poses a significant health challenge.
• Dextran sulfate sodium (DSS)-induced colitis is a widely used murine model for studying intestinal inflammation.
• Identifying novel therapeutic agents for colitis is crucial for improving patient outcomes.

Purpose of the Study:

• To investigate the therapeutic potential of beta-sitosterol in a murine model of experimental colitis.
• To evaluate the impact of beta-sitosterol on inflammatory markers and gut barrier function.
• To explore the effects of beta-sitosterol on intestinal epithelial cells and their response to bacterial pathogens.

Main Methods:

• Induction of experimental colitis in mice using dextran sulfate sodium.
• Administration of beta-sitosterol to assess its effects on clinical and histological parameters.
• Measurement of pro-inflammatory cytokine levels (TNF-α, IL-6, IL-1β) in intestinal tissues.
• In vitro studies on intestinal epithelial cells to evaluate antimicrobial peptide expression and intracellular bacterial survival.

Main Results:

• Beta-sitosterol significantly ameliorated DSS-induced colitis, reducing weight loss and colon shortening.
• Microscopic examination revealed decreased inflammatory infiltration in the colons of beta-sitosterol treated mice.
• Treatment with beta-sitosterol led to a dose-dependent reduction in TNF-α, IL-6, and IL-1β levels.
• In vitro, beta-sitosterol enhanced antimicrobial peptide expression and reduced intracellular Salmonella typhimurium survival in intestinal epithelial cells.

Conclusions:

• Beta-sitosterol demonstrates significant anti-inflammatory and protective effects in experimental colitis.
• The compound’s ability to modulate inflammatory cytokines and enhance antimicrobial defenses suggests a novel therapeutic approach.
• Beta-sitosterol shows promise as a natural agent for managing colonic inflammation and associated infections.